Dengue Fever: Global Travel Health Advisory
The CDC has issued a Level 1 travel health notice regarding dengue fever, which continues to pose a year-round risk in numerous countries across multiple continents. This alert applies to travelers planning visits to affected regions including Colombia, Samoa, Mali, Vietnam, New Caledonia, Timor-Leste, Guyana, Maldives, Bolivia, Tonga, and Cambodia.
Key Facts About Dengue
Dengue is a mosquito-borne viral illness transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes. The disease manifests with symptoms including fever, headache, muscle and joint pain, and rash. While most cases resolve without complications, severe dengue can develop, particularly in individuals with previous dengue infections.
Outbreaks in endemic areas typically occur cyclically every 2–5 years, though transmission may occur year-round in tropical regions. The alert encompasses areas on multiple continents where dengue circulation remains established or seasonal.
Prevention Recommendations
The primary strategy for dengue prevention involves mosquito bite avoidance:
- Insect repellent use: EPA-approved repellents containing DEET (20-30%), picaridin, or oil of lemon eucalyptus
- Protective clothing: Long sleeves, pants, and hats, particularly during dawn and dusk when vectors are most active
- Environmental controls: Air conditioning, window screens, and mosquito netting
- Awareness: Understanding local transmission patterns and high-risk areas
Travel Considerations
Travelers should monitor personal health during and after travel, seeking medical evaluation if fever or characteristic symptoms develop within 14 days of returning from affected regions. Early medical assessment is important for appropriate diagnosis and management.
Pharmacist's Note: While dengue vaccines exist and may be appropriate for certain travelers with previous dengue infection or those in high-risk situations, these are not universally available or recommended for all travelers. Consult with a travel medicine specialist or pharmacist 4–6 weeks before departure to discuss individual risk factors and vaccination eligibility. Pharmacists can also recommend appropriate insect repellents and discuss proper application techniques for maximum effectiveness during extended outdoor activities.
This Level 1 alert indicates ongoing risk without immediate outbreak escalation, emphasizing the importance of consistent prevention practices rather than emergency travel restrictions.